| ID | Type | Location (GRCh37) | Location (GRCh38) | Length | GC content |
|---|---|---|---|---|---|
| hsa_LPAR1_0000100 | Intergenic-Exon | chr9:113509514-113638002 | chr9:110747234-110875722 | 250 nt | 0.4040 |
| hsa_LPAR1_0000300 | Intergenic-Exon | chr9:113547093-113638002 | chr9:110784813-110875722 | 250 nt | 0.3920 |
| hsa_LPAR1_0000600 | Intergenic-Intron | chr9:113597904-113659961 | chr9:110835624-110897681 | 250 nt | 0.2920 |
| hsa_LPAR1_0000700 | Intergenic-Exon | chr9:113611987-113638002 | chr9:110849707-110875722 | 250 nt | 0.3760 |
| hsa_LPAR1_0000900 | Intergenic-Exon | chr9:113614069-113638002 | chr9:110851789-110875722 | 250 nt | 0.3800 |
| hsa_LPAR1_0001100 | Exon-Exon | chr9:113636194-113735838 | chr9:110873914-110973558 | 2783 nt | 0.4053 |
| hsa_LPAR1_0001200 | Exon-Intron | chr9:113636194-113773970 | chr9:110873914-111011690 | 250 nt | 0.2840 |
| hsa_LPAR1_0001400 | Exon-Exon | chr9:113637186-113638002 | chr9:110874906-110875722 | 817 nt | 0.4468 |
| hsa_LPAR1_0001500 | Exon-Exon | chr9:113637186-113735838 | chr9:110874906-110973558 | 226 nt | 0.4956 |
| hsa_LPAR1_0001300 | Exon-Intron | chr9:113637186-113773970 | chr9:110874906-111011690 | 250 nt | 0.2840 |
A study in humans demonstrated that the circLPAR1 is expressed at low levels in muscle-invasive bladder cancer (MIBC) tissues, where its low expression predicts worse disease-specific survival and is associated with invasion and metastasis [Di Agostino et al. DOI:10.3389/fcell.2020.00389].